TriMix Laboratories Announces New TriMix-gel Partnership with KRS Global Biotechnology
BOCA RATON, Fla., April 24, 2013 /PRNewswire/ — TriMix Laboratories LLC today announced an agreement with KRS Global Biotechnology, INC to fill prescriptions for TriMix-gel®. KRS is a licensed compounding pharmacy capable of making TriMix-gel for individual patients in response to a prescription from a licensed physician.
John Swartz, Vice President of Business Development, said, “TriMix-gel will fit perfectly with our expanding urology department and product offering.”
TriMix-gel does not have to be self-injected with a needle. Also, this medicine does not have to be refrigerated and can be carried by the patient at room temperature. Patients are very happy they no longer need to carry their ED medicine in an ice pack.
TriMix-gel is not an herbal remedy; it contains prescription medicine listed in the US Pharmacopeia. Therefore a patient needs a prescription from his physician. A TriMix-gel order form used by physicians is available online. The patient simply gives the form to their doctor who then faxes the patient’s prescription to KRS. The pharmacy ships the medicine to the patient’s home or address of choice.
TriMix Laboratories develops innovative products for the scientific and medical advancement of urology. For more information, visit TriMixgel.com.
KRS is a recognized leader in pharmaceutical compounding, helping Physicians and Veterinarians with medicine precisely customized for each individual patient. For more information, visit www.GBTBIO.com.
The information contained herein is general in nature and is intended for use only as an informational aid. It does not cover all possible uses, actions, precautions, side effects, or interactions of the products shown, nor is the information intended as medical advice or diagnosis for individual health problems. TriMix-gel has not been evaluated by the Food and Drug Administration (FDA) and is not made under GMP requirements. It is compounded in a licensed compounding pharmacy. The compound is for the use of an individual patient who has been prescribed TriMix-gel by a licensed physician. The information contained herein is not intended for making an evaluation as to suitability, risks or benefits. Before taking any action, consult your Physician.
This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.
SOURCE TriMix Laboratories LLC